ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 253 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,442,934 | +26.4% | 43,616 | +0.2% | 0.01% | +33.3% |
| Q2 2023 | $16,957,932 | +20.0% | 43,512 | +14.7% | 0.01% | +12.5% |
| Q1 2023 | $14,137,176 | -8.5% | 37,944 | -7.7% | 0.01% | -20.0% |
| Q4 2022 | $15,453,239 | -9.7% | 41,122 | -14.1% | 0.01% | -16.7% |
| Q3 2022 | $17,112,339 | -1.3% | 47,860 | +3.1% | 0.01% | 0.0% |
| Q2 2022 | $17,335,238 | +27.8% | 46,403 | +7.2% | 0.01% | +33.3% |
| Q1 2022 | $13,565,220 | +452074.0% | 43,273 | +120102.8% | 0.01% | – |
| Q1 2018 | $3,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |